SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNostra Terra Regulatory News (NTOG)

  • There is currently no data for NTOG

Director/PDMR Shareholding

18 Jan 2011 07:00

RNS Number : 6199Z
Nostra Terra Oil & Gas Company PLC
18 January 2011
 



NOSTRA TERRA OIL AND GAS COMPANY PLC

("Nostra Terra", "NTOG" or the "Company")

 

Directors' Dealing/Holdings in Company

Exercise of Warrants and Issue of Equity, Grant of Options

 

18 January 2011

 

Exercise of Warrants and Issue of Equity

 

The Company yesterday received notice that Mr Matt Lofgran, Chief Executive Officer of Nostra Terra, had exercised 62,500,000 Warrants to subscribe for new ordinary 0.1p shares ("New Ordinary Shares") in the Company at a price of 0.1p per share for a total consideration of £62,500 (the "Warrant Exercise").

 

As a result of the Warrant Exercise, Mr. Lofgran is now interested in a total of 62,500,000 ordinary shares in the Company, representing approximately 3.88 per cent. of the Company's issued ordinary share capital, as enlarged by the Warrant Exercise.

 

In addition, Mr Lofgran is interested in a further 15,000,000 ordinary shares, taking his total shareholding to 77,500,000 ordinary shares (approximately 4.81 per cent. of the Company's issued ordinary share capital, as enlarged by the Warrant Exercise) and in 217,842,506 Warrants to subscribe for ordinary shares at a price of 0.1p per share. These additional warrants have not yet vested and remain subject to the satisfaction of certain performance criteria. Once vested, they are capable of exercise at any time, subject to any restrictions contained in the AIM Rules for Companies and the Company's Code on Dealings in Securities (amongst others), until 30 June 2012, subject to extension if the Company is then in a close period as defined in the AIM Rules.

 

Mr. Lofgran is subject to an orderly market agreement with the Company, under which he has agreed not to dispose of any ordinary shares in the Company before 6 July 2011 without the prior approval of the Company and its broker.

 

Following the Warrant Exercise, the Company's issued ordinary share capital will be 1,612,100,913 ordinary shares of 0.1p. Application has been made to the London Stock Exchange for the New Ordinary Shares, which rank pari passu with the Company's existing issued ordinary shares, to be admitted to trading on AIM. Dealings are expected to commence at 8.00 a.m. on 21 January 2011.

 

Grant of Options

 

On 17 January 2011, the Company granted options to subscribe for 3,000,000 ordinary shares of 0.1p each to Mr Stephen Oakes, exerciseable at any time until 14 January 2014 (subject to extension if the Company is then in a close period) at a price of 0.37 pence per share, approximating to the average closing share price of NTOG over the 30 day period prior to grant. Mr Oakes has no other options or warrants over NTOG ordinary shares and is interested in 14,166,666 NTOG ordinary shares, representing approximately 0.88 per cent. of the Company's issued ordinary share capital, as enlarged by the warrant exercise above.

 

For further information, visit www.ntog.co.uk or contact:

 

Nostra Terra Oil and Gas Company plc

Matt Lofgran, CEO

mlofgran@ntog.co.uk Telephone: +1 480 993 8933

 

Religare Capital Markets

Peter Trevelyan-Clark/Ben Jeynes Telephone: +44 (0)20 7444 0800

 

Alexander David Securities Ltd

David Scott/Bill Sharp/Nick Bealer Telephone: +44 (0)20 7448 9820

 

Announcements made by the Company are available automatically by email to those who register at www.ntog.co.uk.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSVDLFFFFFFBBD
Date   Source Headline
26th Jun 20257:00 amRNSChange of Name
20th Jun 202510:40 amRNSResults of Annual General Meeting
3rd Jun 20257:00 amRNS-REngage Investor Presentation
23rd May 20257:00 amRNS2024 Audited Annual Results & Notice of AGM
3rd Apr 20257:00 amRNSPartner Approval for Fouke 3 Well
17th Mar 20257:00 amRNS-REngage Investor Presentation
11th Mar 20257:00 amRNSHolding(s) in Company
4th Mar 20257:00 amRNSCompletion of £500,000 Fundraise
24th Feb 20257:00 amRNSProduction and Operations Update
11th Feb 202512:57 pmRNSHolding(s) in Company
29th Jan 20257:00 amRNS3-Year Renewal of Senior Lending Facility
23rd Jan 20257:00 amRNSHolding(s) in Company
21st Jan 202512:29 pmRNSHolding(s) in Company
21st Jan 20257:05 amRNSIncreased Holdings in the Company
21st Jan 20257:00 amRNSProduction and Operations Update
2nd Jan 20257:00 amRNSBoard Change
27th Dec 20244:35 pmRNSHolding(s) in Company
27th Dec 20247:00 amRNSHolding(s) in Company
28th Nov 202412:15 pmRNSHolding(s) in Company
21st Nov 20247:00 amRNSFundraise to increase production & cash flow
12th Nov 20244:48 pmRNSHolding(s) in Company
11th Nov 20247:00 amRNSProduction and Operations Update
20th Sep 202411:50 amRNSShare Issuance
20th Sep 20247:00 amRNSShare Issuance
19th Sep 20247:00 amRNSInterim Results for six months ended 30 June 2024
6th Sep 20247:00 amRNSChange of Nominated Adviser
29th Aug 202412:30 pmRNSHolding(s) in Company
27th Aug 202412:41 pmRNSHolding(s) in Company
22nd Aug 20244:54 pmRNSHolding(s) in Company
20th Aug 202412:15 pmRNSHolding(s) in Company
19th Aug 20243:52 pmRNSHolding(s) in Company
16th Aug 20244:45 pmRNSHolding(s) in Company
16th Aug 20247:00 amRNSHolding(s) in Company
14th Aug 20244:56 pmRNSHolding(s) in Company
13th Aug 20247:00 amRNSHolding(s) in Company
7th Aug 202411:52 amRNSHolding(s) in Company
2nd Aug 20244:28 pmRNSDirector Increases Participation in Fundraise
29th Jul 20247:00 amRNS£450,000 Fundraise aimed at increasing production
17th Jul 202411:08 amRNSAdvisor Change
17th Jul 202410:13 amRNSResult of Meeting
1st Jul 20245:00 pmRNSCorporate Update & Notice of General Meeting
27th Jun 20242:46 pmRNSResult of AGM
27th Jun 20247:00 amRNSAppointment of Non-Executive Director
13th Jun 20247:00 amRNSProposed Appointment of Non-Executive Director
31st May 20247:00 amRNSFinal Results
20th May 20248:01 amRNSBoard Changes
22nd Feb 20247:00 amRNSHolding(s) in Company
6th Feb 20249:23 amRNSHolding(s) in Company
30th Jan 20249:37 amRNSHolding(s) in Company
30th Jan 20249:34 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.